OptimizeRx Corp - Common Stock, par value $0.001 (OPRX)

Historical Holders from Q2 2018 to Q1 2025

Symbol
OPRX on Nasdaq
CUSIP
68401U204
Type / Class
Equity / Common Stock, par value $0.001
Shares outstanding
18.4M
All holders as of December 31, 2024
Q4 2024
Shares, excl. options
11.4M
Holdings value
$55.3M
% of all portfolios
0.001%
Grand Portfolio weight change
0%
Number of holders
85
Number of buys
47
Number of sells
-35
Average Value change %
0%
Average buys %
+0%
Average sells %
-0.001%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of OptimizeRx Corp - Common Stock, par value $0.001 (OPRX)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Whetstone Capital Advisors, LLC 8.2% 0% $13.1M 1.51M 0% Whetstone Capital Advisors, LLC Apr 18, 2025
ROYCE & ASSOCIATES LP 5.81% $9.26M 1.07M ROYCE & ASSOCIATES LP Dec 31, 2024
Samjo Management, LLC 0% $433 50 SAMJO MANAGEMENT, LLC Dec 31, 2024

Institutional Holders of OptimizeRx Corp - Common Stock, par value $0.001 (OPRX)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q1 155K $1.34M -$95.4K $8.66 6
2024 Q4 11.4M $55.3M -$15.7M $4.86 85
2024 Q3 12.4M $95.5M -$9.64M $7.72 83
2024 Q2 13.1M $131M +$5.23M $10.00 92
2024 Q1 12.8M $155M +$1.81M $12.15 98
2023 Q4 12.5M $179M -$2.58M $14.31 97
2023 Q3 13.1M $102M -$8.01M $7.78 93
2023 Q2 12.8M $183M -$8.7M $14.29 99
2023 Q1 13.3M $194M -$6.84M $14.63 106
2022 Q4 13.7M $230M +$942K $16.80 122
2022 Q3 13.2M $196M -$65.5M $14.82 110
2022 Q2 15M $412M -$1M $27.39 131
2022 Q1 15.4M $581M +$1.66M $37.71 139
2021 Q4 14.9M $926M +$61.5M $62.11 171
2021 Q3 13.8M $1.18B +$103M $85.55 156
2021 Q2 12.2M $755M +$44.7M $61.90 135
2021 Q1 11.5M $561M +$75.2M $48.75 115
2020 Q4 9.92M $309M +$7.62M $31.16 81
2020 Q3 8.85M $184M +$17.6M $20.85 65
2020 Q2 8.46M $110M +$12.6M $13.03 52
2020 Q1 7.29M $66M -$4.24M $9.06 48
2019 Q4 8.36M $85.8M +$5.16M $10.27 54
2019 Q3 7.53M $109M +$13.7M $14.48 61
2019 Q2 6.37M $103M +$32.6M $16.20 51
2019 Q1 4.51M $57.4M +$4.43M $12.72 40
2018 Q4 4.19M $45.9M +$15.9M $10.97 38
2018 Q3 2.68M $48.3M +$11.5M $18.00 29
2018 Q2 2.05M $21.3M +$21.2M $10.40 13